Autopsy report · NCT07169162

ADZENYS XR-ODT™ in Children (4 to <6 Years) Diagnosed With Attention-deficit/Hyperactivity Disorder

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Enrollment never started”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 4
Sponsor: Aytu BioPharma, Inc.
Sponsor type: Industry
Conditions: Attention Deficit Hyperactivity Disorder
Interventions: ADZENYS XR-ODT; Placebo Oral Tablet
Participants: 0
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.